Literature DB >> 732051

Use of intra-aortic balloon pumping (IABP) in clinical cardiac surgery and management of patients with IABP.

H Watanabe, W D Johnson, R T Shore, K L Kayser.   

Abstract

One hundred thirty eight patients were reviewed which required IABP assist. Sixty nine (84 per cent) of 82 patients who had been able to come off cardiopulmonary bypass despite increasing pharmacologic support survived operation and 56 patients (68 per cent) discharged hospital. Twenty three (75 per cent) of 31 patients who took for elective coronary artery surgery as extremely high risk because of extensive three vessel coronary artery disease and severely compromised left ventricular function discharged hospital. In summary, hospital death was 35 per cent, late death 12 per cent and long term survivors 54 per cent. Severe complication concerned with inserting balloon catheter occurred in two cases (1.4 per cent) which were abdominal aortic dissection and laceration of iliac artery. At the present time, the primary indication for IABP is in assistance of the open heart surgical patient. Thre are three important factors in successfully managing the patients with IABP. First, begin IABP assist as soon as possible if indicated. Second, keep an adequate circulating volume with mean left atrial pressure being maintained around 20 mmHg and cardiac index at 2.1 L/min./M or greater. Third, improve the peripheral vascular circulation, which might need peripheral vasodilator.

Entities:  

Mesh:

Year:  1978        PMID: 732051     DOI: 10.1007/bf02469410

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  15 in total

1.  Diastolic balloon pumping (with carbon dioxide) in the aorta--a mechanical assistance to the failing circulation.

Authors:  S D MOULOPOULOS; S TOPAZ; W J KOLFF
Journal:  Am Heart J       Date:  1962-05       Impact factor: 4.749

2.  Left ventricular hemorrhagic necrosis.

Authors:  H Najafi; D Henson; W S Dye; H Javid; J A Hunter; R Callaghan; R Eisenstein; O C Julian
Journal:  Ann Thorac Surg       Date:  1969-06       Impact factor: 4.330

3.  Intra-aortic balloon pump assist for cardiogenic shock after cardiopulmonary bypass.

Authors:  M J Buckley; J M Craver; H K Gold; E D Mundth; W M Daggett; W G Austen
Journal:  Circulation       Date:  1973-07       Impact factor: 29.690

4.  Subendocardial ischemia after cardiopulmonary bypass.

Authors:  G D Buckberg; B Towers; D E Paglia; D G Mulder; J V Maloney
Journal:  J Thorac Cardiovasc Surg       Date:  1972-11       Impact factor: 5.209

5.  Effects of intraaortic balloon counterpulsation on the severity of myocardial ischemic injury following acute coronary occlusion. Counterpulsation and myocardial injury.

Authors:  P R Maroko; E F Bernstein; P Libby; G A DeLaria; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1972-06       Impact factor: 29.690

6.  Mechanical circulatory assistance. Current status and experience with combining circulatory assistance, emergency coronary angiography, and acute myocardial revascularization.

Authors:  C A Sanders; M J Buckley; R C Leinbach; E D Mundth; W G Austen
Journal:  Circulation       Date:  1972-06       Impact factor: 29.690

7.  Physiologic principles in the application of circulatory assist for the failing heart. Intraaortic balloon circulatory assist and venoarterial phased partial bypass.

Authors:  E Corday; H J Swan; T W Lang; A Goldman; J M Matloff; H Gold; S Meerbaum
Journal:  Am J Cardiol       Date:  1970-12       Impact factor: 2.778

Review 8.  Mechanical and surgical interventions for the reduction of myocardial ischemia.

Authors:  E D Mundth
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

9.  Intraoperative unidirectional intra-aortic balloon pumping in the management of left ventricular power failure.

Authors:  D Bregman; E N Parodi; R N Edie; F O Bowman; K Reemtsma; J R Malm
Journal:  J Thorac Cardiovasc Surg       Date:  1975-12       Impact factor: 5.209

10.  Assessment of intra-aortic balloon counterpulsation in cardiogenic shock.

Authors:  D Bregman
Journal:  Crit Care Med       Date:  1975 May-Jun       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.